QIM
RIGL icon

Quantitative Investment Management’s Rigel Pharmaceuticals RIGL Stock Holding History

Quantitative Investment Management’s Portfolio RIGL Stock Details RIGL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q1 		– Sell
-2,820
Closed -$109K – 895
2017
Q4 		$109K Buy
+2,820
New +$107K ﹤0.01% 729

Other funds holding RIGL

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
GPP
Great Point Partners Greenwich, Connecticut $435M AUM 318.81% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BC
Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return
O
OppenheimerFunds New York $80.4B AUM 15.1% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return

Quantitative Investment Management's RIGL Position: Q1 2018 in Review

Quantitative Investment Management sold out of Rigel Pharmaceuticals (RIGL) in Q1 2018, closing a stake of 2,820 shares — an estimated $109K sold.

Quantitative Investment Management first reported a position in RIGL in Q4 2017 and held it in 1 quarter. The position peaked at $109K in Q4 2017. 117 funds tracked by Wall St. Rank hold RIGL as of Q1 2018.

  • Quantitative Investment Management reported no remaining Rigel Pharmaceuticals position as of Q1 2018 after selling out during the quarter.
  • Quantitative Investment Management sold 2,820 Rigel Pharmaceuticals shares in Q1 2018, an estimated $109K.
  • Quantitative Investment Management first reported a position in Rigel Pharmaceuticals in Q4 2017 and held it in 1 quarter.
  • Quantitative Investment Management's Rigel Pharmaceuticals position peaked at $109K in Q4 2017.
  • 117 funds tracked by Wall St. Rank held Rigel Pharmaceuticals as of Q1 2018.

Based on Quantitative Investment Management's 13F filing for Q1 2018, filed 15 May 2018.